arXiv ScienceSearch

arXiv subjects

Mojtaba Safari

Publications and source records attributed to Mojtaba Safari.

At least 19 recordsLinked to original sources

A radiographic world model for clinical reasoning and evidence generation

Medical imaging artificial intelligence (AI) is commonly developed as separate mappings from radiographs to diagnostic outputs or from clinical descriptions to generated images, although both arise from the same underlying radiographic state. A world-model formulation instead seeks to learn an internal representation of this state that can support both clinical readout and conditional simulation of radiographic observations. Here we introduce MedDream, a radiographic world model that learns a shared continuous latent state from paired chest radiograph-text observations for diagnostic reasoning and report-conditioned evidence generation. MedDream was pretrained on 2.65 million leakage-controlled chest radiograph-text pairs curated from 4.40 million candidates. Across eight clinical datasets and two independent reader cohorts, MedDream outperformed leading diagnostic and generative comparators. For diagnostic reasoning, MedDream showed strong generalization across disease recognition, label-scarce adaptation, severity assessment, and localization, while MedDream-supported review increased mean resident concordance with independent radiologist consensus from 56.3% to 63.0%. For evidence generation, MedDream produced radiographs that preserved clinically relevant pathology and improved downstream performance on held-out real data, with synthetic augmentation increasing external VinDr-CXR macro-AUROC from 76.4% to 81.4%. More importantly, conditioning generation on prespecified subgroup performance gaps enabled targeted evidence construction, increasing weighted F1 by 3.1 percentage points in Asian patients, whereas matched-volume unguided augmentation decreased it by 2.3 points. These findings establish radiographic world models as a path toward medical AI that learns clinically meaningful internal states for interpreting, simulating, and constructing evidence for clinical use.

cs.AI

Motion Artifact-Aware Self-Supervised Representation Learning for 3D Brain MRI Motion Artifact Reduction

Patient motion remains a source of image degradation in brain MRI, leading to signal loss, blurring, and geometric distortion that compromise quantitative analysis. Existing deep learning methods for motion correction typically rely on paired clean-corrupted data or k-space acquisitions, which are rarely available in clinical settings. We propose SSRL-MAR, a motion artifact-aware unpaired representation learning framework for motion artifact reduction that requires neither paired training data nor explicit motion labels. SSRL-MAR employed a three-stage training strategy: (1) contrastive learning on 3D patches to extract motion representations by contrasting clean and synthetically corrupted images, (2) a motion artifact-aware synthesis network to generate motion artifacts from clean scans, and (3) a motion artifact-aware generator to restore clean volumes using the learned degrader for self-supervised supervision. On in-silico dataset, SSRL-MAR achieved PSNR 23.81dB, SSIM 91.55%, and NMSE 0.79%. On in-vivo MR-ART dataset, the pretrained model reduced motion distortion, and unsupervised domain adaptation further improved anatomical fidelity. Against a source-only supervised model trained on the same simulated pairs, SSRL-MAR improved PSNR by up to 2.0 dB on MR-ART after unsupervised domain adaptation, and remained within 0.25-0.47 dB of an oracle supervised model that requires real paired data unavailable in practice. At the milder motion level, volumetric error in structures such as the corpus callosum and ventricular system decreased by more than 50%, confirming improved neuroanatomical consistency. These results indicate that SSRL-MAR provides a robust and scalable image-domain solution for 3D brain MRI motion correction, enabling reliable structural quantification in large-scale neuroimaging studies without requiring prospectively acquired pairs or acquisition-specific calibration.

cs.CV

MRI super-resolution in ten sampling steps using a diffusion bridge model

Objective. MRI provides excellent soft-tissue contrast, but long acquisition times can cause patient discomfort and lead to motion artifacts, forcing a trade-off between spatial resolution and scan time. Diffusion-based super-resolution (SR) reconstructs high-resolution (HR) images from low-resolution (LR) inputs, but typically needs many sampling steps and initializes from a Gaussian prior ill-suited to image restoration. We developed an efficient diffusion framework that reconstructs HR MRI directly from LR data. Approach. We propose super-resolution diffusion bridge model (SR-DBM), a super-resolution diffusion bridge model that casts SR as a stochastic transport between the LR and HR image distributions. Through a Doob's h-transform of a mean-reverting stochastic differential equation, SR-DBM pins the process to the paired HR and LR images at its endpoints, initializing reconstruction from the measured anatomy rather than from Gaussian noise. The HR image is recovered by a deterministic reverse trajectory in which a network predicts the clean image at each of only ten sampling steps. We evaluated SR-DBM on ultra-high-field 7T brain T1 MP2RAGE maps and pelvic T2-weighted prostate images against nine comparison methods using PSNR, SSIM, GMSD, and LPIPS. Main results. SR-DBM attained the highest PSNR and SSIM and the lowest GMSD on both datasets (brain: 27.66+-1.52 dB, 0.96+-0.02, 7.96+-1.86$; prostate: 27.87+-2.29 dB, 0.80+-0.05, 8.38+- 1.44), with statistically significant gains over every comparison method (two-sided Wilcoxon signed-rank test with Holm correction, p<0.05). The strongest baseline, SR-EMamba, ranked second. Qualitatively, SR-DBM produced the smallest residual errors and best preserved fine structures and lesions.

cs.CV

Text-Guided Refinement of Multi-sequence Glioma Subregion Segmentation with a Vision-Language Foundation Model

Background: Accurate glioma subregion delineation is important for radiotherapy planning and longitudinal monitoring, but manual contour correction is time-consuming. Models such as nnU-Net may generalize imperfectly and lack clinician-directed text correction. Purpose: We investigated adapting a three-dimensional (3D) vision-language foundation model for text-guided brain tumor segmentation refinement. Methods: We developed a lightweight VoxTell-based framework. Pretrained VoxTell generated initial masks. Oracle prompts derived from segmentation errors encoded target, action, location, imaging evidence, edit size, and preservation constraints. Frozen Qwen/VoxTell prompt embeddings were injected through trainable projections into its multiscale decoder conditioning; other weights remained frozen. Training, validation, and testing used 901, 100, and 250 BraTS-GLI cases. Cross-dataset transfer was evaluated on 100 meningioma, metastasis, pediatric tumor, and UPENN-GBM cases. Results: On the internal test set using post-contrast T1-weighted input, correct instructions improved subregion Dice similarity coefficient (DSC; enhancing tumor, edema, and necrotic/non-enhancing core) from $0.774\pm0.158$ to $0.796\pm0.137$. They outperformed blank prompts ($0.762\pm0.155$; Holm-adjusted $p<0.001$, $d_z=0.71$) and contradictory prompts ($0.770\pm0.163$; $p<0.001$, $d_z=0.48$). In cross-dataset testing, correct instructions improved DSC from $0.527\pm0.287$ to $0.550\pm0.278$ and outperformed contradictory instructions ($0.504\pm0.275$; $p<0.001$, $d_z=0.43$). Conclusion: A 3D vision-language foundation model can perform instruction-guided refinement of glioma subregion segmentations. Sensitivity to correct, blank, and contradictory prompts suggests text-dependent contour editing rather than nonspecific post-processing, supporting further evaluation as a clinician-in-the-loop tool.

cs.CV

One-for-All Adaptive Radiotherapy Planning Agent: A Foundation Framework for Daily CBCT-guided Radiotherapy

In this work, we introduce the One-for-All Adaptive Radiotherapy Planning Agent, a unified foundation-model-based system that performs complete, treatment-specific online adaptive planning directly from daily cone-beam CT in under two minutes. The agent first autonomously predicts all essential planning components, including synthetic CT generation, multimodal alignment, and tumor/organ segmentation. It then intelligently leverages these outputs to execute the final clinical plan design, providing a comprehensive, automated solution for daily treatment. We also demonstrate that the agent enables clinicians to define planning with intent and intervene at critical decision points, ensuring a "human-in-the-loop" framework that generates acceptable plans before final approval. Evaluated on multiple datasets spanning head-and-neck, lung, abdominal, and prostate cancers with both photon and proton therapy, the proposed framework achieves clinically acceptable accuracy and plan quality comparable to clinically generated treatment plans, with target dose errors (D98) generally within 2.0 Gy of the reference plan. The strong performance of the One-for-All agent highlights the promise of a unified foundation-model approach and opens opportunities for fast, scalable, and fully automated online adaptive radiotherapy across diverse clinical scenarios.

physics.med-ph

BrainDINO: A Brain MRI Foundation Model for Generalizable Clinical Representation Learning

Brain MRI underpins a wide range of neuroscientific and clinical applications, yet most learning-based methods remain task-specific and require substantial labeled data. Here we show that a single self-supervised representation can generalize across heterogeneous brain MRI endpoints. We trained BrainDINO, a self-distilled foundation model, on approximately 6.6 million unlabeled axial slices from 20 datasets encompassing broad variation in population, disease, and acquisition setting. Using a frozen encoder with lightweight task heads, BrainDINO supported transfer across tumor segmentation, neurodegenerative and neurodevelopmental conditions classification, brain age estimation, post-stroke temporal prediction, molecular status prediction, MRI sequence classification, and survival modeling. Across tasks and supervision regimes, BrainDINO consistently equaled or exceeded natural-image and MRI-specific self-supervised baselines, with particularly strong advantages under label scarcity. Representation analyses further showed anatomically organized and pathology-sensitive feature structure in the absence of task-specific supervision. Our findings indicate that large-scale slice-wise self-supervised learning can yield a unified brain MRI representation that supports diverse neuroimaging tasks without volumetric pretraining or full-network fine-tuning, establishing a scalable foundation for robust and data-efficient brain imaging analysis. Code is available at https://github.com/mclwu22/BrainDINO

cs.LG

Explainable Cross-Disease Reasoning for Cardiovascular Risk Assessment from Low-Dose Computed Tomography

Low-dose chest computed tomography (LDCT) captures pulmonary and cardiac structures in a single scan, enabling joint assessment of lung and cardiovascular health. Existing approaches typically model these domains independently and do not explicitly represent their physiological interactions. We propose an Explainable Cross-Disease Reasoning Framework for cardiovascular risk assessment from LDCT. The framework follows a constrained clinical-information pathway: it extracts pulmonary findings, grounds cross-organ mechanisms in medical knowledge, and produces a cardiovascular prediction with a natural-language rationale. It combines four components: a frozen lung-risk prior, a pulmonary perception module, an agentic reasoning module, and a cardiac subvolume feature extractor. Their outputs are fused to integrate localized cardiac evidence with mechanism-level pulmonary context. On the National Lung Screening Trial cohort, the framework achieves an AUC of 0.919 for CVD screening and up to 0.838 for CVD mortality prediction, outperforming cardiac-specific, single-disease, and foundation-model baselines. Targeted controls indicate that the gains are not explained by additional thoracic visual features alone, fixed rule propagation, or a single reasoning backend. The proposed framework thus provides an auditable approach to cross-disease cardiovascular risk assessment from LDCT.

cs.CV

Universal CT Representations from Anatomy to Disease Phenotype through Agglomerative Pretraining

Computed tomography (CT) is a central to three-dimensional medical imaging, yet CT-based artificial intelligence remains fragmented across task-specific models for segmentation, classification, registration, and report analysis. Here we present FlexiCT, a family of CT foundation models trained by agglomerative continual pretraining on 266,227 CT volumes from 56 publicly available datasets, forming a large-scale public resource for CT representation learning. FlexiCT uses agglomerative pretraining across three stages: two-dimensional axial pretraining, three-dimensional anatomical pretraining and report-guided semantic alignment. This training strategy supports slice-level, volume-level and vision-language analysis. Across five downstream task families (segmentation, classification, registration, vision-language understanding and clinical retrieval), FlexiCT matches or exceeds prior task-specific approaches on multiple benchmarks. Its embeddings further organize CT scans along gradients associated with various tumor stages, suggesting that CT foundation models can capture imaging features relevant to disease phenotype characterization. Project page and code are available at: https://ricklisz.github.io/flexict.github.io and https://github.com/ricklisz/FlexiCT.

cs.CV

Efficient Vision Mamba for MRI Super-Resolution via Hybrid Selective Scanning

Background: High-resolution MRI is critical for diagnosis, but long acquisition times limit clinical use. Super-resolution (SR) can enhance resolution post-scan, yet existing deep learning methods face fidelity-efficiency trade-offs. Purpose: To develop a computationally efficient and accurate deep learning framework for MRI SR that preserves anatomical detail for clinical integration. Materials and Methods: We propose a novel SR framework combining multi-head selective state-space models (MHSSM) with a lightweight channel MLP. The model uses 2D patch extraction with hybrid scanning to capture long-range dependencies. Each MambaFormer block integrates MHSSM, depthwise convolutions, and gated channel mixing. Evaluation used 7T brain T1 MP2RAGE maps (n=142) and 1.5T prostate T2w MRI (n=334). Comparisons included Bicubic interpolation, GANs (CycleGAN, Pix2pix, SPSR), transformers (SwinIR), Mamba (MambaIR), and diffusion models (I2SB, Res-SRDiff). Results: Our model achieved superior performance with exceptional efficiency. For 7T brain data: SSIM=0.951+-0.021, PSNR=26.90+-1.41 dB, LPIPS=0.076+-0.022, GMSD=0.083+-0.017, significantly outperforming all baselines (p<0.001). For prostate data: SSIM=0.770+-0.049, PSNR=27.15+-2.19 dB, LPIPS=0.190+-0.095, GMSD=0.087+-0.013. The framework used only 0.9M parameters and 57 GFLOPs, reducing parameters by 99.8% and computation by 97.5% versus Res-SRDiff, while outperforming SwinIR and MambaIR in accuracy and efficiency. Conclusion: The proposed framework provides an efficient, accurate MRI SR solution, delivering enhanced anatomical detail across datasets. Its low computational demand and state-of-the-art performance show strong potential for clinical translation.

cs.CV

Evaluating GPT-5 as a Multimodal Clinical Reasoner: A Landscape Commentary

The transition from task-specific artificial intelligence toward general-purpose foundation models raises fundamental questions about their capacity to support the integrated reasoning required in clinical medicine, where diagnosis demands synthesis of ambiguous patient narratives, laboratory data, and multimodal imaging. This landscape commentary provides the first controlled, cross-sectional evaluation of the GPT-5 family (GPT-5, GPT-5 Mini, GPT-5 Nano) against its predecessor GPT-4o across a diverse spectrum of clinically grounded tasks, including medical education examinations, text-based reasoning benchmarks, and visual question-answering in neuroradiology, digital pathology, and mammography using a standardized zero-shot chain-of-thought protocol. GPT-5 demonstrated substantial gains in expert-level textual reasoning, with absolute improvements exceeding 25 percentage-points on MedXpertQA. When tasked with multimodal synthesis, GPT-5 effectively leveraged this enhanced reasoning capacity to ground uncertain clinical narratives in concrete imaging evidence, achieving state-of-the-art or competitive performance across most VQA benchmarks and outperforming GPT-4o by margins of 10-40% in mammography tasks requiring fine-grained lesion characterization. However, performance remained moderate in neuroradiology (44% macro-average accuracy) and lagged behind domain-specific models in mammography, where specialized systems exceed 80% accuracy compared to GPT-5's 52-64%. These findings indicate that while GPT-5 represents a meaningful advance toward integrated multimodal clinical reasoning, mirroring the clinician's cognitive process of biasing uncertain information with objective findings, generalist models are not yet substitutes for purpose-built systems in highly specialized, perception-critical tasks.

cs.CV

Generalizable 7T T1-map Synthesis from 1.5T and 3T T1 MRI with an Efficient Transformer Model

Purpose: Ultra-high-field 7T MRI offers improved resolution and contrast over standard clinical field strengths (1.5T, 3T). However, 7T scanners are costly, scarce, and introduce additional challenges such as susceptibility artifacts. We propose an efficient transformer-based model (7T-Restormer) to synthesize 7T-quality T1-maps from routine 1.5T or 3T T1-weighted (T1W) images. Methods: Our model was validated on 35 1.5T and 108 3T T1w MRI paired with corresponding 7T T1 maps of patients with confirmed MS. A total of 141 patient cases (32,128 slices) were randomly divided into 105 (25; 80) training cases (19,204 slices), 19 (5; 14) validation cases (3,476 slices), and 17 (5; 14) test cases (3,145 slices) where (X; Y) denotes the patients with 1.5T and 3T T1W scans, respectively. The synthetic 7T T1 maps were compared against the ResViT and ResShift models. Results: The 7T-Restormer model achieved a PSNR of 26.0 +/- 4.6 dB, SSIM of 0.861 +/- 0.072, and NMSE of 0.019 +/- 0.011 for 1.5T inputs, and 25.9 +/- 4.9 dB, and 0.866 +/- 0.077 for 3T inputs, respectively. Using 10.5 M parameters, our model reduced NMSE by 64 % relative to 56.7M parameter ResShift (0.019 vs 0.052, p = <.001 and by 41 % relative to 70.4M parameter ResViT (0.019 vs 0.032, p = <.001) at 1.5T, with similar advantages at 3T (0.021 vs 0.060 and 0.033; p < .001). Training with a mixed 1.5 T + 3 T corpus was superior to single-field strategies. Restricting the model to 1.5T increased the 1.5T NMSE from 0.019 to 0.021 (p = 1.1E-3) while training solely on 3T resulted in lower performance on input 1.5T T1W MRI. Conclusion: We propose a novel method for predicting quantitative 7T MP2RAGE maps from 1.5T and 3T T1W scans with higher quality than existing state-of-the-art methods. Our approach makes the benefits of 7T MRI more accessible to standard clinical workflows.

cs.CV

Low-Dose CT Imaging Using a Regularization-Enhanced Efficient Diffusion Probabilistic Model

Low-dose computed tomography (LDCT) reduces patient radiation exposure but introduces substantial noise that degrades image quality and hinders diagnostic accuracy. Existing denoising approaches often require many diffusion steps, limiting real-time applicability. We propose a Regularization-Enhanced Efficient Diffusion Probabilistic Model (RE-EDPM), a rapid and high-fidelity LDCT denoising framework that integrates a residual shifting mechanism to align low-dose and full-dose distributions and performs only four reverse diffusion steps using a Swin-based U-Net backbone. A composite loss combining pixel reconstruction, perceptual similarity (LPIPS), and total variation (TV) regularization effectively suppresses spatially varying noise while preserving anatomical structures. RE-EDPM was evaluated on a public LDCT benchmark across dose levels and anatomical sites. On 10 percent dose chest and 25 percent dose abdominal scans, it achieved SSIM = 0.879 (0.068), PSNR = 31.60 (2.52) dB, VIFp = 0.366 (0.121) for chest, and SSIM = 0.971 (0.000), PSNR = 36.69 (2.54) dB, VIFp = 0.510 (0.007) for abdomen. Visual and statistical analyses, including ablation and Wilcoxon signed-rank tests (p < 0.05), confirm significant contributions from residual shifting and regularization terms. RE-EDPM processes two 512x512 slices in about 0.25 s on modern GPUs, supporting near real-time clinical use. The proposed framework achieves an optimal balance between noise suppression and anatomical fidelity, offering an efficient solution for LDCT restoration and broader medical image enhancement tasks.

physics.med-ph

Foundation Models in Medical Image Analysis: A Systematic Review and Meta-Analysis

Recent advancements in artificial intelligence (AI), particularly foundation models (FMs), have revolutionized medical image analysis, demonstrating strong zero- and few-shot performance across diverse medical imaging tasks, from segmentation to report generation. Unlike traditional task-specific AI models, FMs leverage large corpora of labeled and unlabeled multimodal datasets to learn generalized representations that can be adapted to various downstream clinical applications with minimal fine-tuning. However, despite the rapid proliferation of FM research in medical imaging, the field remains fragmented, lacking a unified synthesis that systematically maps the evolution of architectures, training paradigms, and clinical applications across modalities. To address this gap, this review article provides a comprehensive and structured analysis of FMs in medical image analysis. We systematically categorize studies into vision-only and vision-language FMs based on their architectural foundations, training strategies, and downstream clinical tasks. Additionally, a quantitative meta-analysis of the studies was conducted to characterize temporal trends in dataset utilization and application domains. We also critically discuss persistent challenges, including domain adaptation, efficient fine-tuning, computational constraints, and interpretability along with emerging solutions such as federated learning, knowledge distillation, and advanced prompting. Finally, we identify key future research directions aimed at enhancing the robustness, explainability, and clinical integration of FMs, thereby accelerating their translation into real-world medical practice.

cs.CV

An Efficient 3D Latent Diffusion Model for T1-contrast Enhanced MRI Generation

Objective: Gadolinium-based contrast agents (GBCAs) are commonly employed with T1w MRI to enhance lesion visualization but are restricted in patients at risk of nephrogenic systemic fibrosis and variations in GBCA administration can introduce imaging inconsistencies. This study develops an efficient 3D deep-learning framework to generate T1-contrast enhanced images (T1C) from pre-contrast multiparametric MRI. Approach: We propose the 3D latent rectified flow (T1C-RFlow) model for generating high-quality T1C images. First, T1w and T2-FLAIR images are input into a pretrained autoencoder to acquire an efficient latent space representation. A rectified flow diffusion model is then trained in this latent space representation. The T1C-RFlow model was trained on a curated dataset comprised of the BraTS 2024 glioma (GLI; 1480 patients), meningioma (MEN; 1141 patients), and metastases (MET; 1475 patients) datasets. Selected patients were split into train (N=2860), validation (N=612), and test (N=614) sets. Results: Both qualitative and quantitative results demonstrate that the T1C-RFlow model outperforms benchmark 3D models (pix2pix, DDPM, Diffusion Transformers (DiT-3D)) trained in the same latent space. T1C-RFlow achieved the following metrics - GLI: NMSE 0.044 +/- 0.047, SSIM 0.935 +/- 0.025; MEN: NMSE 0.046 +/- 0.029, SSIM 0.937 +/- 0.021; MET: NMSE 0.098 +/- 0.088, SSIM 0.905 +/- 0.082. T1C-RFlow had the best tumor reconstruction performance and significantly faster denoising times (6.9 s/volume, 200 steps) than conventional DDPM models in both latent space (37.7s, 1000 steps) and patch-based in image space (4.3 hr/volume). Significance: Our proposed method generates synthetic T1C images that closely resemble ground truth T1C in much less time than previous diffusion models. Further development may permit a practical method for contrast-agent-free MRI for brain tumors.

cs.CV

Systematic Review and Meta-analysis of AI-driven MRI Motion Artifact Detection and Correction

Background: To systematically review and perform a meta-analysis of artificial intelligence (AI)-driven methods for detecting and correcting magnetic resonance imaging (MRI) motion artifacts, assessing current developments, effectiveness, challenges, and future research directions. Methods: A comprehensive systematic review and meta-analysis were conducted, focusing on deep learning (DL) approaches, particularly generative models, for the detection and correction of MRI motion artifacts. Quantitative data were extracted regarding utilized datasets, DL architectures, and performance metrics. Results: DL, particularly generative models, show promise for reducing motion artifacts and improving image quality; however, limited generalizability, reliance on paired training data, and risk of visual distortions remain key challenges that motivate standardized datasets and reporting. Conclusions: AI-driven methods, particularly DL generative models, show significant potential for improving MRI image quality by effectively addressing motion artifacts. However, critical challenges must be addressed, including the need for comprehensive public datasets, standardized reporting protocols for artifact levels, and more advanced, adaptable DL techniques to reduce reliance on extensive paired datasets. Addressing these aspects could substantially enhance MRI diagnostic accuracy, reduce healthcare costs, and improve patient care outcomes.

cs.CV

Res-MoCoDiff: Residual-guided diffusion models for motion artifact correction in brain MRI

Objective. Motion artifacts in brain MRI, mainly from rigid head motion, degrade image quality and hinder downstream applications. Conventional methods to mitigate these artifacts, including repeated acquisitions or motion tracking, impose workflow burdens. This study introduces Res-MoCoDiff, an efficient denoising diffusion probabilistic model specifically designed for MRI motion artifact correction.Approach.Res-MoCoDiff exploits a novel residual error shifting mechanism during the forward diffusion process to incorporate information from motion-corrupted images. This mechanism allows the model to simulate the evolution of noise with a probability distribution closely matching that of the corrupted data, enabling a reverse diffusion process that requires only four steps. The model employs a U-net backbone, with attention layers replaced by Swin Transformer blocks, to enhance robustness across resolutions. Furthermore, the training process integrates a combined l1+l2 loss function, which promotes image sharpness and reduces pixel-level errors. Res-MoCoDiff was evaluated on both an in-silico dataset generated using a realistic motion simulation framework and an in-vivo MR-ART dataset. Comparative analyses were conducted against established methods, including CycleGAN, Pix2pix, and a diffusion model with a vision transformer backbone, using quantitative metrics such as PSNR, SSIM, and NMSE.Main results. The proposed method demonstrated superior performance in removing motion artifacts across minor, moderate, and heavy distortion levels. Res-MoCoDiff consistently achieved the highest SSIM and the lowest NMSE values, with a PSNR of up to 41.91+-2.94 dB for minor distortions. Notably, the average sampling time was reduced to 0.37 seconds per batch of two image slices, compared with 101.74 seconds for conventional approaches.

cs.CV

DINOv3 with Test-Time Training for Medical Image Registration

Prior medical image registration approaches, particularly learning-based methods, often require large amounts of training data, which constrains clinical adoption. To overcome this limitation, we propose a training-free pipeline that relies on a frozen DINOv3 encoder and test-time optimization of the deformation field in feature space. Across two representative benchmarks, the method is accurate and yields regular deformations. On Abdomen MR-CT, it attained the best mean Dice score (DSC) of 0.790 together with the lowest 95th percentile Hausdorff Distance (HD95) of 4.9+-5.0 and the lowest standard deviation of Log-Jacobian (SDLogJ) of 0.08+-0.02. On ACDC cardiac MRI, it improves mean DSC to 0.769 and reduces SDLogJ to 0.11 and HD95 to 4.8, a marked gain over the initial alignment. The results indicate that operating in a compact foundation feature space at test time offers a practical and general solution for clinical registration without additional training.

cs.CV

Is ChatGPT-5 Ready for Mammogram VQA?

Mammogram visual question answering (VQA) integrates image interpretation with clinical reasoning and has potential to support breast cancer screening. We systematically evaluated the GPT-5 family and GPT-4o model on four public mammography datasets (EMBED, InBreast, CMMD, CBIS-DDSM) for BI-RADS assessment, abnormality detection, and malignancy classification tasks. GPT-5 consistently was the best performing model but lagged behind both human experts and domain-specific fine-tuned models. On EMBED, GPT-5 achieved the highest scores among GPT variants in density (56.8%), distortion (52.5%), mass (64.5%), calcification (63.5%), and malignancy (52.8%) classification. On InBreast, it attained 36.9% BI-RADS accuracy, 45.9% abnormality detection, and 35.0% malignancy classification. On CMMD, GPT-5 reached 32.3% abnormality detection and 55.0% malignancy accuracy. On CBIS-DDSM, it achieved 69.3% BI-RADS accuracy, 66.0% abnormality detection, and 58.2% malignancy accuracy. Compared with human expert estimations, GPT-5 exhibited lower sensitivity (63.5%) and specificity (52.3%). While GPT-5 exhibits promising capabilities for screening tasks, its performance remains insufficient for high-stakes clinical imaging applications without targeted domain adaptation and optimization. However, the tremendous improvements in performance from GPT-4o to GPT-5 show a promising trend in the potential for general large language models (LLMs) to assist with mammography VQA tasks.

cs.CV